|
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Higher plasma CD36 levels were associated with higher diabetes risk, but the association was not independent of adiposity.
|
31701685 |
2020 |
|
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
Instead, a trend toward higher diabetes related CD36+/CD235a+ MP levels was associated with lower 24hUNa (rho = -0.23, <i>P</i>=0.05).
|
30249722 |
2018 |
|
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
Therefore, the new insights make CD36 attractive as a therapeutic target for diabetes.
|
29359682 |
2018 |
|
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
High CD36 levels were only found to be associated with risk of CHD in combination with prevalent diabetes (HR = 2.83, 95% CI: 1.08-7.45) vs. the joint reference group of lowest CD36 tertile and no diabetes.
|
30218892 |
2018 |
|
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
The cluster of differentiation 36 (CD36) is implicated in the intake of long-chain fatty acids and fat storage in various cell types including the pancreatic beta cell, thus contributing to the pathogenesis of metabolic stress and diabetes.
|
29274335 |
2018 |
|
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
Scavenger receptor CD36 is associated with increasing risk of diabetes and atherosclerosis, and may play a role in cognitive deficits.
|
28883843 |
2017 |
|
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
Single nucleotide polymorphisms (SNPs) in genes for scavenger receptors such as CD36 have been implicated in the pathogenesis of atherosclerosis and cardiovascular diseases in diabetes.
|
23844572 |
2013 |
|
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
Higher levels of monocyte CD36 and plasma CD36(sCD36) are seen to cluster with insulin resistance and diabetes.
|
24069322 |
2013 |
|
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
CD36 has been studied in patients with diabetes and hypertension extensively; however, few studies have focused on the relationship of the CD36 gene with impaired fasting glucose (IFG)/impaired glucose tolerance (IGT) or T2D in essential hypertension patients.
|
22869067 |
2012 |
|
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Correlation between the anti-CD36 activity of these inhibitors and the known pathophysiological activity of this scavenger receptor in the development of atherosclerosis and diabetes were observed at pharmacological doses.
|
22662181 |
2012 |
|
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
The scavenger receptor FAT/CD36 contributes to the inflammation associated with diabetes, atherosclerosis, thrombosis, and Alzheimer disease.
|
21454644 |
2011 |
|
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Receptor of advanced glycation end products (RAGE) positively regulates CD36 expression and reactive oxygen species production in human monocytes in diabetes.
|
19190027 |
2010 |
|
Diabetes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In addition, variants in the CD36 gene were shown recently to influence susceptibility for the metabolic syndrome, which greatly increases the risk of diabetes and heart disease.
|
19185504 |
2009 |
|
Diabetes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Genetic variation in the CD36 gene may contribute to the aetiology of diabetes.
|
16911630 |
2006 |
|
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this study, we investigated the role of CD36 in cultured microvascular endothelial cells (MVECs) and in the heart by using an animal model of chronic diabetes.
|
15915335 |
2005 |
|
Diabetes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A nominal evidence for linkage of familial T2D at the CD36 locus led us to identify a rare nonsense mutation c.1079T>G (p.L360X) in one Caucasian pedigree presenting with autosomal dominant diabetes.
|
15221799 |
2004 |
|
Diabetes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Diabetes duration may modify the association between genetic variation in the glycoprotein Ia subunit of the platelet collagen receptor and risk of severe diabetic retinopathy: a working hypothesis.
|
12540964 |
2003 |
|
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Monocyte CD36 expression (by laser flow cytometry), plasma LDL diene conjugates, plasma LDL hydroxyoctadecadienoic acid-13 (a peroxisome proliferator activator receptor gamma agonist) were measured at 0, 2 and 4 h. Mean monocyte CD36 expression at baseline was 34% higher in the diabetes group (P=0.01), did not change during acute hyperglycaemia and plasma LDL conjugated diene concentration was the only variable directly related to CD36 expression (F=4.53; P=0.05; r=0.51).
|
12618277 |
2003 |
|
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation.
|
11433350 |
2001 |
|
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
A sensitive immunoassay for rat fatty acid translocase (CD36) using phage antibodies selected on cell transfectants: abundant presence of fatty acid translocase/CD36 in cardiac and red skeletal muscle and up-regulation in diabetes.
|
9895283 |
1999 |